Loading...
01/11 13:56
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A session reveal a strong financial performance with record high book value and shareholder equity per share. Despite a decrease in operating income per share, the company has robust share repurchase plans and dividend returns. The Q&A provides reassurance on potential risks, such as the Thames Water exposure and Puerto Rico restructuring. The market cap suggests a moderate reaction, leading to a positive stock price movement prediction.
Adjusted book value per share $176.95, reached a record high at the end of the second quarter of 2025.
Adjusted operating shareholders' equity per share $120.11, reached a record high at the end of the second quarter of 2025.
Adjusted operating income per share $1.01 for the second quarter of 2025, compared to $1.44 in the second quarter of 2024, a decrease due to changes in fair value of alternative investments and trading securities, and an increase in Insurance segment loss expense.
Net earned premiums and credit derivative revenues Increased by $5 million in Q2 2025 compared to Q2 2024, primarily due to earnings on new large transactions and supplemental premiums written in 2024.
Net investment income on the available-for-sale portfolio Increased by $8 million in Q2 2025 compared to Q2 2024, due to reclassification of certain CLO equity tranche investments and reinvestment into higher-yielding assets.
Deferred premium revenue $3.9 billion, representing future store earnings.
Insurance segment loss expense Increased by $27 million in Q2 2025 compared to Q2 2024, primarily due to additional reserves on certain U.K. regulated utility and U.S. municipal revenue exposures.
Share repurchases 1.5 million shares repurchased for $131 million at an average price of $85.03 per share in Q2 2025.
Dividends $19 million returned to shareholders in Q2 2025.
Adjusted book value per share: Reached a record high of $176.95 at the end of Q2 2025.
Adjusted operating shareholders' equity per share: Reached a record high of $120.11 at the end of Q2 2025.
Adjusted operating income per share: $4.21 for the first half and $1.01 for Q2 2025.
U.S. municipal issuance: Increased by 17% compared to the previous year, with Assured Guaranty insuring 64% of the insured par sold in the primary market during the first half of 2025.
Secondary market policies: Nearly $900 million written in the first half of 2025, including over $500 million in Q2 2025, representing 150% of the total secondary par insured in all of 2024.
Global infrastructure and structured finance: Expanded with transactions in the U.K., Spain, and France, including the first post-financial crisis P3 transaction in Spain and the first primary transaction in French infrastructure since opening the Paris office.
Share repurchase program: Target of $500 million for 2025, with $296 million repurchased as of August 6, 2025, representing 6.8% of shares outstanding as of December 31, 2024.
Stock redemption: A $250 million stock redemption or special dividend approved by the Maryland regulator in July 2025.
Financial strength ratings: S&P Global Ratings affirmed AA rating with a stable outlook, and KBRA affirmed AA+ rating with a stable outlook.
Growth trajectory: Focus on increasing the size of the insured portfolio and maintaining leadership in U.S. municipal bond insurance while expanding global infrastructure and structured finance reach.
High-quality business mix: Shift towards insuring higher-quality credits, with 32% of insured par in the first half of 2025 being AA-rated credits, a 50% increase over the previous three years.
Economic loss development: The company experienced $36 million in economic loss development in Q2 2025, primarily due to exposures in healthcare, U.K. regulated utilities, and U.S. municipal revenue sectors. This indicates potential vulnerabilities in these areas.
Insurance segment loss expense: Loss expenses increased by $27 million in Q2 2025 compared to the prior year, driven by additional reserves for U.K. regulated utility and U.S. municipal revenue exposures. This reflects ongoing challenges in managing these liabilities.
Volatility in alternative investments: Earnings from alternative investments were volatile, with a $5 million NAV change in Q2 2025 compared to $15 million in Q2 2024. This unpredictability could impact financial stability.
Fair value of trading securities: The fair value of trading securities, including Puerto Rico contingent value instruments, showed volatility with a $2 million gain in Q2 2025 compared to a $17 million gain in Q2 2024. This highlights risks in the trading portfolio.
Deferred premium revenue: The deferred premium revenue, a future earnings store, was $3.9 billion. While this is a positive metric, it underscores the reliance on future premium earnings, which could be impacted by market conditions.
Exposure to large transactions: The company is involved in large transactions, such as the $600 million Terminal 1 project at JFK Airport. While these projects offer growth opportunities, they also carry significant financial and operational risks.
Growth trajectory in U.S. and non-U.S. markets: The company believes it is on a growth trajectory in both U.S. and non-U.S. markets. It plans to continue its leadership position in U.S. municipal bond insurance while expanding and diversifying its global infrastructure and structured finance reach.
Subscription finance growth: The company has seen growth in subscription finance since 2021 and expects this growth to continue in the coming years.
Third quarter 2025 outlook: The company is off to a good start in the third quarter, having insured approximately $2.8 billion in par closed in July 2025. This includes a $600 million par for the new Terminal 1 at New York's JFK Airport. The company is also in the process of closing another substantial transaction in Australia.
U.S. municipal market projections: The U.S. municipal market is seeing high issuance, with forecasts projecting that municipal issuance in 2025 will surpass 2024's record of $500 billion. Total market volume had already reached $278 billion by June 30, 2025.
Global infrastructure and structured finance opportunities: The company sees many attractive opportunities in global infrastructure and structured finance and is confident in its strategy for the second half of the year.
Special Dividend: In July, a $250 million stock redemption or a special dividend by the U.S. insurance subsidiary was approved by the Maryland regulator.
Regular Dividends: $19 million in dividends were returned to shareholders in the second quarter of 2025.
Share Repurchase Program: The company has a target of $500 million for share repurchases in 2025. As of August 6, 2025, $296 million worth of common shares were repurchased, representing 6.8% of the shares outstanding as of December 31, 2024.
Additional Share Repurchase Authorization: In August, the Board authorized an additional $300 million for share repurchases, bringing the remaining authorization to $356 million.
The earnings call highlights strong financial performance, record high metrics, and a robust share repurchase program, suggesting positive sentiment. The Q&A section reveals confidence in managing risks and exploring new opportunities, with analysts generally satisfied despite some unclear responses. Adjustments for potential risks are minor compared to the positive financial indicators. Given the market cap, the stock is likely to experience a positive reaction in the 2% to 8% range.
The earnings call summary and Q&A session reveal a strong financial performance with record high book value and shareholder equity per share. Despite a decrease in operating income per share, the company has robust share repurchase plans and dividend returns. The Q&A provides reassurance on potential risks, such as the Thames Water exposure and Puerto Rico restructuring. The market cap suggests a moderate reaction, leading to a positive stock price movement prediction.
The earnings call summary shows strong financial performance with a 62% increase in adjusted operating income per share and a significant litigation gain. The company also demonstrated commitment to shareholder returns through share repurchases and dividend increases. Despite some regulatory and investment risks, the positive outlook on revenue and strategic geographic expansion suggests optimism. The Q&A section did not reveal critical negative insights. Given the market cap of approximately $4.2 billion, the stock is likely to experience a positive movement of 2% to 8% over the next two weeks.
The earnings call summary shows mixed signals: record high adjusted book value and equity per share, and strong share repurchase program, yet declining operating income and increased loss expenses. The Q&A reveals confidence in certain areas, but management's unclear responses on some issues raise concerns. Overall, the financial performance and shareholder returns are positive, but uncertainties in guidance and loss expenses balance the sentiment, leading to a neutral outlook.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
